4:03 PM ET
10-Q
Financial Results
Verastem Q3 2026 Results: Net Loss of $74.7M, Loss Narrows
Verastem reported Q3 2026 net product revenue of $24.0 million, a significant increase from $11.2 million in the prior year, driven by AVMAPKI FAKZYNJA CO-PACK sales. Despite a GAAP net loss of $74.7 million, the company strengthened its balance sheet with a $250 million follow-on offering in October, extending its cash runway into the first half of 2028.
- Key figure
- Net loss $74.7M